SCHEMBL2909615

SCHEMBL2909615

O=C(NC1CCCCC1)C(C1CCCCC1)C1(C(O)c2cccnc2)Nc2cc(F)c(F)cc2N1

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
C3AR1 Q16581 8/20 0.43
TSHR P16473 2/20 0.42
ALDH1A1 P00352 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
OPRM1 P35372 1/20 0.42
OPRD1 P41143 1/20 0.42
MDM2 Q00987 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
POLB P06746 1/20 0.40
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2913040 0.88 TSHR (0.44) C3AR1TSHRALDH1A1CYP3A4CYP2C19
SCHEMBL2907592 0.84 NPC1 (0.42) TSHRCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL2915021 0.82 KCNH2 (0.44) TSHRALDH1A1CYP3A4CYP2D6CYP2C9
SCHEMBL2912425 0.82 TSHR (0.40) C3AR1TSHRALDH1A1CYP3A4CYP2C19
SCHEMBL2915028 0.82 KMT2A (0.43) C3AR1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL2906901 0.77 CNR1 (0.40) TSHRALDH1A1CYP3A4CYP2D6CYP2C9
SCHEMBL4036707 0.77 C3AR1 (0.41) C3AR1ALDH1A1CYP3A4CYP2D6CYP2C9
SCHEMBL2910028 0.77 SMN1; SMN2 (0.45) C3AR1TSHRALDH1A1CYP3A4CYP2C19
SCHEMBL2306977 0.75 NR1H4 (0.43) C3AR1CYP2D6CYP2C9CYP2C19SMN1; SMN2
SCHEMBL2912405 0.74 ALDH1A1 (0.40) TSHRALDH1A1CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP claimed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO claimed
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP disclosed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO disclosed